rolipram has been researched along with Brain Disorders in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gurney, ME | 1 |
Nugent, RA | 1 |
Mo, X | 1 |
Sindac, JA | 1 |
Hagen, TJ | 1 |
Fox, D | 1 |
O'Donnell, JM | 1 |
Zhang, C | 1 |
Xu, Y | 1 |
Zhang, HT | 1 |
Groppi, VE | 1 |
Bailie, M | 1 |
White, RE | 1 |
Romero, DL | 1 |
Vellekoop, AS | 1 |
Walker, JR | 1 |
Surman, MD | 1 |
Zhu, L | 1 |
Campbell, RF | 1 |
Block, F | 1 |
Loos, M | 1 |
Frohn, C | 1 |
Schwarz, M | 1 |
Okayama, A | 1 |
Mikasa, K | 1 |
Matsui, N | 1 |
Higashi, N | 1 |
Miyamoto, M | 1 |
Kita, E | 1 |
3 other studies available for rolipram and Brain Disorders
Article | Year |
---|---|
Design and Synthesis of Selective Phosphodiesterase 4D (PDE4D) Allosteric Inhibitors for the Treatment of Fragile X Syndrome and Other Brain Disorders.
Topics: Allosteric Regulation; Animals; Behavior, Animal; Brain Diseases; Cyclic Nucleotide Phosphodiesteras | 2019 |
Association between inflammation and nigral neuronal damage following striatal excitotoxic lesion.
Topics: Animals; Brain Diseases; Cell Count; Chondroitin Sulfate Proteoglycans; Corpus Striatum; Dizocilpine | 2004 |
An interventional approach to block brain damage caused by Shiga toxin-producing Escherichia coli infection, by use of a combination of phosphodiesterase inhibitors.
Topics: Animals; Antigens, Tumor-Associated, Carbohydrate; Brain Diseases; Cecum; Cells, Cultured; Cytokines | 2004 |